Tivic Health Systems, Inc. - Common stock (TIVC)

Competitors to Tivic Health Systems, Inc. - Common stock (TIVC)

Auris Health, Inc.

Auris Health targets the respiratory health sector with advanced robotic technologies for minimally invasive surgery, positioning itself not just as a competitor in therapeutic approaches but also in procedural innovations surrounding respiratory treatments. While Tivic Health Systems aims for a less invasive neuromodulation device for sinusitis, Auris's competence in surgical robotics could provide it with a significant foothold in the market by addressing both the treatment and procedural aspects of respiratory health more broadly.

Helen of Troy Limited 

Helen of Troy Limited, through its OXO and Vicks brands, provides consumer health products that include nasal relief devices. They compete in the same overall market space focused on respiratory health and symptom relief, but Helen of Troy's extensive brand recognition and established market presence provide a competitive advantage. Tivic's approach, focused on a technologically innovative and targeted neuromodulation treatment, allows it to differentiate itself, although it might struggle against the brand loyalty that Helen of Troy commands in the consumer space.

NeuroSigma, Inc.

NeuroSigma develops non-invasive neuromodulation devices aimed primarily at treating neurological disorders such as depression and epilepsy. Both companies are in the neurotechnology space, but Tivic focuses on sinus-related conditions, while NeuroSigma has a more extensive application range for mental health disorders. NeuroSigma's established track record in treating a variety of conditions gives it a competitive advantage in terms of clinical validation, whereas Tivic's innovation in a specific area could allow it to capture a specialized market.

Nuvectra Corporation

Nuvectra focuses on developing neurostimulation technologies for various conditions, including chronic pain and neurological disorders. Tivic Health Systems, with its focus on non-invasive neuromodulation for sinusitis, competes by addressing a specific niche within the broader neuromodulation market that enhances patient comfort and reduces reliance on medications. The two companies compete for market share within the neurostimulation domain, but Nuvectra's broader application of its technology for various indications gives it a potentially wider target market.

Triton Health

Triton Health produces healthcare solutions that include non-invasive devices for pain management and other therapeutic areas. Similar to Tivic Health Systems, they leverage neuromodulation technology, positioning themselves against each other in segments focused on non-invasive treatments. However, Triton has a broader portfolio of products, which may provide a strong competitive edge by offering comprehensive solutions to healthcare providers, while Tivic aims at carving out specific niches within the sinus and respiratory treatment market.